A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment
- PMID: 32506456
- DOI: 10.1111/apt.15811
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment
Abstract
Background: To evaluate medical versus interventional treatment (transjugular thrombus fragmentation, local thrombolysis with or without stent implantation) in patients with acute non-cirrhotic, non-malignant portal vein thrombosis (PVT).
Methods: This prospective, observational study enrolled 65 patients with acute (<28 days since begin of symptoms, no cavernoma) PVT in nine centres. Thirty patients received medical treatment and 35 patients received interventional treatment. PVT was graded into grade 1: short thrombosis and incomplete occlusion of the vessel lumen and grade 2: extended thrombosis or complete occlusion. Treatment response was classified as partial or complete, if thrombosis was reduced by one grade or to <25% of the vessel diameter respectively.
Results: Partial and complete response rates were 7% and 30% in the medical compared to 17% and 54% (P < 0.001) in the interventional treatment group. In the multivariate analysis, interventional treatment showed a strong positive (OR 4.32, P < 0.016) and a myeloproliferative aetiology a negative (OR 0.09, P = 0.006) prediction of complete response. Complications were rare in the medical group and consisted of septicaemia and upper gastrointestinal bleeding of unknown origin in one patient each. Interventional treatment was accompanied by mild and self-limiting bleeding complications in nine patients, moderate intra-abdominal bleeding requiring transfusions (2 units) in one patient and peritoneal bleeding requiring surgical rescue in one patient. Four patients in each group developed intestinal gangrene requiring surgery. One patient died 52 days after unsuccessful interventional treatment.
Conclusions: Compared to medical treatment alone, interventional treatment doubled response rates at the cost of increased bleeding complications.
© 2020 The Authors. Alimentary Pharmacology & Therapeutics published byJohn Wiley & Sons Ltd.
Comment in
-
Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis--who should be candidates for interventional treatment? Authors' reply.Aliment Pharmacol Ther. 2020 Aug;52(4):729-730. doi: 10.1111/apt.15930. Aliment Pharmacol Ther. 2020. PMID: 32886377 No abstract available.
-
Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis-who should be candidates for interventional treatment?Aliment Pharmacol Ther. 2020 Aug;52(4):725-728. doi: 10.1111/apt.15902. Aliment Pharmacol Ther. 2020. PMID: 32886391 No abstract available.
References
REFERENCES
-
- Ögren M, Bergqvist D, Björck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23796 consecutive autopsies. World J Gastroenterol. 2006;12:2115-2119
-
- Rajani R, Björnsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: a mulicentre study. Aliment Pharmacol Ther. 2010;32:1154-1162
-
- Deleve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764
-
- European Association for the Study of the Liver. Clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64:179-202
-
- Tait C, Baglin T, Watson H, et al. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol. 2012;159:28-38
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical